Cargando…

Commentary on – “Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction”

Detalles Bibliográficos
Autores principales: Cao, De-Hong, Liu, Liang-Ren, Wei, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577604/
https://www.ncbi.nlm.nih.gov/pubmed/25652635
http://dx.doi.org/10.4103/1008-682X.148069
_version_ 1782390991646359552
author Cao, De-Hong
Liu, Liang-Ren
Wei, Qiang
author_facet Cao, De-Hong
Liu, Liang-Ren
Wei, Qiang
author_sort Cao, De-Hong
collection PubMed
description
format Online
Article
Text
id pubmed-4577604
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-45776042015-09-23 Commentary on – “Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction” Cao, De-Hong Liu, Liang-Ren Wei, Qiang Asian J Androl Letter to the Editor Medknow Publications & Media Pvt Ltd 2015 2015-01-16 /pmc/articles/PMC4577604/ /pubmed/25652635 http://dx.doi.org/10.4103/1008-682X.148069 Text en Copyright: © Asian Journal of Andrology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms
spellingShingle Letter to the Editor
Cao, De-Hong
Liu, Liang-Ren
Wei, Qiang
Commentary on – “Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction”
title Commentary on – “Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction”
title_full Commentary on – “Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction”
title_fullStr Commentary on – “Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction”
title_full_unstemmed Commentary on – “Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction”
title_short Commentary on – “Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction”
title_sort commentary on – “comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577604/
https://www.ncbi.nlm.nih.gov/pubmed/25652635
http://dx.doi.org/10.4103/1008-682X.148069
work_keys_str_mv AT caodehong commentaryoncomparisonoftheefficacyandsafetyofoncedailydosingandondemanduseofudenafilfortype2diabeticpatientswitherectiledysfunction
AT liuliangren commentaryoncomparisonoftheefficacyandsafetyofoncedailydosingandondemanduseofudenafilfortype2diabeticpatientswitherectiledysfunction
AT weiqiang commentaryoncomparisonoftheefficacyandsafetyofoncedailydosingandondemanduseofudenafilfortype2diabeticpatientswitherectiledysfunction